Replies to post #32459 on Biotech Values

[mskatiescarletohara]

ANDS CC....listening to yesterday's CC, lots of talk, salvage type. "They don't expect to resume studies for ANA975 for SEVERAL QUARTERS?" They have serious toxicity issues with this compound, I predict NVS will walk, just like the CEO.

katie....